Importance of Public-Private Partnerships: Strengthening Laboratory Medicine Systems and Clinical Practice in Africa
Published Date:Apr 15 2016
Source:J Infect Dis. 213(Suppl 2):S35-S40.
Keywords:Acquired Immunodeficiency Syndrome
Becton, Dickinson And Company
Centers For Disease Control And Prevention (U.S.)
Public-Private Sector Partnerships
Pubmed Central ID:PMC4817354
Funding:CC999999/Intramural CDC HHS/United States
Description:After the launch of the US President's Emergency Plan for AIDS Relief in 2003, it became evident that inadequate laboratory systems and services would severely limit the scale-up of human immunodeficiency virus infection prevention, care, and treatment programs. Thus, the Office of the US Global AIDS Coordinator, Centers for Disease Control and Prevention, and Becton, Dickinson and Company developed a public-private partnership (PPP). Between October 2007 and July 2012, the PPP combined the competencies of the public and private sectors to boost sustainable laboratory systems and develop workforce skills in 4 African countries. Key accomplishments of the initiative include measurable and scalable outcomes to strengthen national capacities to build technical skills, develop sample referral networks, map disease prevalence, support evidence-based health programming, and drive continuous quality improvement in laboratories. This report details lessons learned from our experience and a series of recommendations on how to achieve successful PPPs.
You May Also Like: